| aOR (95%CI) | p value |
---|---|---|
Sex | ||
 Male (ref) | ||
  Female | 1.39 (1.05–1.83) | 0.019 |
  Age, years | 0.98 (0.97–0.99) | 0.005 |
  HIV infection | 0.56 (0.42–0.75) |  < 0.001 |
COVID-19 vaccination | ||
 One dose/two doses (ref) | ||
  Three doses | 1.02 (0.75–1.38) | 0.879 |
  Four dosesa | 0.18 (0.11–0.28) |  < 0.001 |
  Unvaccinated | 0.65 (0.40–1.06) | 0.089 |
  Diabetes | 0.86 (0.45–1.65) | 0.662 |
  Cardiovascular and cerebrovascular diseases | 0.92 (0.58–1.46) | 0.745 |
  Chronic lung diseases | 1.09 (0.52–2.28) | 0.811 |
  Chronic kidney diseases | 0.51 (0.21–1.23) | 0.137 |
  Chronic liver Diseases | 0.78 (0.41–1.46) | 0.443 |